DZ2945A1 - Formulations antiparasitaires contenant une avermectine ou milbémycine, et procédé pour leur préparation. - Google Patents

Formulations antiparasitaires contenant une avermectine ou milbémycine, et procédé pour leur préparation.

Info

Publication number
DZ2945A1
DZ2945A1 DZ990245A DZ990245A DZ2945A1 DZ 2945 A1 DZ2945 A1 DZ 2945A1 DZ 990245 A DZ990245 A DZ 990245A DZ 990245 A DZ990245 A DZ 990245A DZ 2945 A1 DZ2945 A1 DZ 2945A1
Authority
DZ
Algeria
Prior art keywords
milbemycin
avermectin
preparation
formulations containing
antiparasitic formulations
Prior art date
Application number
DZ990245A
Other languages
English (en)
French (fr)
Inventor
Timothy Michael Lukas
Stephen Richard Wicks
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10842728&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DZ2945(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of DZ2945A1 publication Critical patent/DZ2945A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dentistry (AREA)
  • Molecular Biology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
DZ990245A 1998-11-19 1999-11-17 Formulations antiparasitaires contenant une avermectine ou milbémycine, et procédé pour leur préparation. DZ2945A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9825402.2A GB9825402D0 (en) 1998-11-19 1998-11-19 Antiparasitic formulations

Publications (1)

Publication Number Publication Date
DZ2945A1 true DZ2945A1 (fr) 2004-03-15

Family

ID=10842728

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ990245A DZ2945A1 (fr) 1998-11-19 1999-11-17 Formulations antiparasitaires contenant une avermectine ou milbémycine, et procédé pour leur préparation.

Country Status (43)

Country Link
US (1) US6797701B2 (da)
EP (2) EP1130966B2 (da)
JP (1) JP3507799B2 (da)
KR (1) KR100458406B1 (da)
CN (1) CN1147232C (da)
AP (1) AP1210A (da)
AR (1) AR023062A1 (da)
AT (2) ATE288201T1 (da)
BG (1) BG65440B1 (da)
BR (1) BR9915458B1 (da)
CA (1) CA2351730C (da)
CO (1) CO5150175A1 (da)
CY (1) CY1111955T1 (da)
CZ (1) CZ304345B6 (da)
DE (2) DE69942465D1 (da)
DK (2) DK1522219T3 (da)
DZ (1) DZ2945A1 (da)
EA (1) EA003959B1 (da)
ES (2) ES2344505T3 (da)
GB (1) GB9825402D0 (da)
GT (1) GT199900197A (da)
HK (1) HK1040593B (da)
HR (1) HRP20010368B1 (da)
HU (1) HU229493B1 (da)
ID (1) ID28698A (da)
IL (3) IL142104A0 (da)
IS (1) IS5907A (da)
MA (1) MA25029A1 (da)
NO (1) NO20012389L (da)
NZ (2) NZ510678A (da)
OA (1) OA11678A (da)
PA (1) PA8485501A1 (da)
PE (1) PE20001319A1 (da)
PL (1) PL204763B1 (da)
PT (2) PT1130966E (da)
SI (2) SI1130966T2 (da)
SK (1) SK287540B6 (da)
TN (1) TNSN99213A1 (da)
TW (1) TW526045B (da)
UY (1) UY25806A1 (da)
WO (1) WO2000030449A1 (da)
YU (1) YU23401A (da)
ZA (1) ZA997174B (da)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6426333B1 (en) 1996-09-19 2002-07-30 Merial Spot-on formulations for combating parasites
US6998131B2 (en) 1996-09-19 2006-02-14 Merial Limited Spot-on formulations for combating parasites
FR2753377B1 (fr) 1996-09-19 1999-09-24 Rhone Merieux Nouvelle association parasiticide a base de 1-n-phenylpyra- zoles et de lactones macrocycliques endectocides
GB9825402D0 (en) * 1998-11-19 1999-01-13 Pfizer Ltd Antiparasitic formulations
EP1215964A4 (en) * 1999-09-22 2002-11-05 Ashmont Holdings Ltd POUR-ON COMPOSITION FOR SHEEP
AUPQ441699A0 (en) 1999-12-02 2000-01-06 Eli Lilly And Company Pour-on formulations
GB0108485D0 (en) * 2001-04-04 2001-05-23 Pfizer Ltd Combination therapy
US20030064941A1 (en) * 2001-05-21 2003-04-03 Pfizer Inc. Avermectin and praziquantel combination therapy
ES2365993T5 (es) 2001-09-17 2020-06-25 Elanco Us Inc Formulaciones pesticidas
KR100600402B1 (ko) * 2002-05-22 2006-07-14 주식회사 엘지생명과학 피부 도포용 이버멕틴 조성물 및 그 제조방법
US20040151759A1 (en) * 2002-08-16 2004-08-05 Douglas Cleverly Non-animal product containing veterinary formulations
US20040037869A1 (en) * 2002-08-16 2004-02-26 Douglas Cleverly Non-animal product containing veterinary formulations
US7666444B2 (en) * 2004-02-02 2010-02-23 Wyeth Antiparasitic composition
DE102004053964A1 (de) * 2004-11-09 2006-05-11 Bayer Healthcare Ag Mittel gegen Demodikose
GB2444572B (en) * 2006-12-05 2011-10-19 Michael Hilary Burke A process for the preparation of a stable anhydrous anthelmintic formulation
CA2750626C (en) * 2009-02-16 2013-10-01 Pfizer Inc. High dosage doramectin formulation
AU2010224685A1 (en) 2009-03-18 2011-11-03 Fidopharm, Inc. Parasiticidal formulation
UA108641C2 (uk) 2010-04-02 2015-05-25 Паразитицидна композиція, яка містить чотири активних агенти, та спосіб її застосування
BRPI1002174A2 (pt) * 2010-06-17 2012-03-13 Rotam Agrochem International Company Ltd Composição agroquímica, uso de um éter c2-c4 dialquileno glicol di-/mono-c1-c4 aquil, método para reduzir irritação ocular de formulações inseticidas líquidas, método de tratamento de praga em loco e uso da composição
BR112013002177B8 (pt) * 2010-07-30 2019-03-06 Ceva Sante Animale composição de uma droga veterinária para uso no controle de infestações por verme do coração em uma cobaia animal não humana, e kit para tratamento e/ou prevenção de infestação parasitária por verme do coração em uma cobaia animal não humana
CA2811926A1 (en) * 2010-10-20 2012-04-26 Galderma S.A. Method of treating otitis externa using macrocyclic lactone compound
IT1403631B1 (it) * 2011-01-14 2013-10-31 Gsi Geosyntec Invest B V Metodo e dispositivo per la posa e il tensionamento di una copertura impermeabile, per opere idrauliche in materiale sciolto.
BG1461U1 (bg) * 2011-03-18 2011-07-29 "Ендектовет" Еоод Състави за противопаразитно лекарствено средство
BRPI1104180A2 (pt) * 2011-08-25 2013-08-13 Eurofarma Lab Ltda composiÇÕes veterinÁrias pour on nço residuais, uso, kit, e mÉtodo de tratamento de parasitoses
BR112014009406A2 (pt) * 2011-10-18 2017-04-18 Agronomique Inst Nat Rech uso de derivados de avermectina para aumentar a biodisponibilidade e eficácia de lactonas macrocíclicas
DK3351546T5 (da) 2011-12-02 2024-08-12 Boehringer Ingelheim Vetmedica Gmbh Langtidsvirkende injicerbare moxidectinformuleringer
BR112014024606B1 (pt) * 2012-04-04 2022-11-16 Syngenta Participations Ag Composição de macrólido pesticida não aquosa
AR094882A1 (es) 2013-02-26 2015-09-02 Zoetis Llc Selamectina para el tratamiento de las infestaciones por piojos de mar, composición
US20160081986A1 (en) * 2013-05-20 2016-03-24 Zoetis Services Llc Long-acting spiro-isoxazoline antiparasitic compositions
PL3595441T3 (pl) 2017-03-17 2023-12-04 Krka, D.D., Novo Mesto Stabilna kompozycja weterynaryjna do stosowania miejscowego
JP7274479B2 (ja) * 2017-11-23 2023-05-16 セバ・サンテ・アニマル 寄生虫の寄生を治療するためのモキシデクチンを含有する組成物
SI3723739T1 (sl) 2017-12-15 2024-08-30 Tarsus Pharmaceuticals, Inc. Paraziticidni pripravki na osnovi izoksazolina in njihova uporaba za zdravljenje blefaritisa

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4914624A (da) * 1972-06-08 1974-02-08
US3839234A (en) 1973-01-26 1974-10-01 C Roscoe Multi-purpose cleaning concentrate
SE434277B (sv) * 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
US4206205A (en) 1977-10-03 1980-06-03 Merck & Co., Inc. Monosaccharide and aglycone derivatives of C-076
GB2095107A (en) * 1981-03-24 1982-09-29 Janssen Pharmaceutica Nv Tetramisole-or levamisole pour-on compositions
EP0170006B1 (en) * 1984-06-05 1992-07-08 American Cyanamid Company Method and compositions for helmintic, arthropod ectoparasitic and acaridal infections with novel agents
DE3587294T2 (de) 1985-01-22 1993-09-30 Saint Gobain Vitrage Verfahren zur Herstellung einer dünnen Metalloxidbeschichtung auf einem Substrat, insbesondere Glas und deren Verwendung als Verglasung.
ES8800986A1 (es) * 1985-07-27 1987-12-01 Pfizer Un procedimiento para la produccion de un nuevo derivado de avermectina
DE3545529A1 (de) 1985-12-20 1987-07-02 Autotyp Sa Schneekette fuer fahrzeugraeder
LU86393A1 (fr) 1986-04-16 1987-12-07 Oreal Composition anti-acneique stable a base d'erythromycine
JP2587241B2 (ja) * 1986-07-24 1997-03-05 ビ−チヤム・グル−プ・ピ−エルシ− 新規化合物、その製法及びそれを含む医薬組成物
ES2058244T3 (es) * 1987-01-23 1994-11-01 Pfizer Procedimiento para produccion de avermectinas y cultivos para el mismo.
DE3727648A1 (de) † 1987-08-19 1989-03-02 Bayer Ag Neue avermectin derivate, verfahren zu ihrer herstellung und ihre verwendung
GB8721647D0 (en) * 1987-09-15 1987-10-21 Pfizer Ltd Antiparasitic agents
GB8726730D0 (en) * 1987-11-14 1987-12-16 Pfizer Ltd Antiparasitic agents
GB8804440D0 (en) * 1988-02-25 1988-03-23 Pfizer Ltd Antiparasitic agents
GB8807280D0 (en) * 1988-03-26 1988-04-27 Pfizer Ltd Antiparasitic agents
FR2630576B1 (fr) * 1988-04-26 1990-08-17 Realisations Nucleaires Et Dispositif d'amelioration de la duree de vie et de la fiabilite d'un tube neutronique scelle a haut flux
GB8815967D0 (en) 1988-07-05 1988-08-10 Pfizer Ltd Antiparasitic agents
US5015630A (en) 1989-01-19 1991-05-14 Merck & Co., Inc. 5-oxime avermectin derivatives
US4973468A (en) † 1989-03-22 1990-11-27 Cygnus Research Corporation Skin permeation enhancer compositions
GB8917064D0 (en) * 1989-07-26 1989-09-13 Pfizer Ltd Antiparasitic agent
JP2978245B2 (ja) † 1990-03-05 1999-11-15 マリンクロット ベタリナリイ，インコーポレイテッド 寄生虫防除組成物ならびにその製造法および使用法
GB9121028D0 (en) 1991-10-03 1991-11-13 Pfizer Ltd Therapeutic agents
US5411737A (en) † 1991-10-15 1995-05-02 Merck & Co., Inc. Slow release syneresing polymeric drug delivery device
GB9300883D0 (en) * 1993-01-18 1993-03-10 Pfizer Ltd Antiparasitic agents
JP3966479B2 (ja) * 1993-04-16 2007-08-29 日本テキサス・インスツルメンツ株式会社 ゾルーゲル法による強誘電体膜の形成方法及びキャパシタの製造方法
PL173487B1 (pl) * 1993-05-10 1998-03-31 Merck & Co Inc Preparat do zwalczania wewnętrznych i zewnętrznych pasożytów zwierząt, sposób wytwarzania preparatu do zwalczania wewnętrznych i zewnętrznych pasożytów zwierząt oraz sposób zwalczania zewnętrznych pasożytów zwierząt
TW327125B (en) * 1994-02-07 1998-02-21 Merck & Co Inc Composition and method for protecting against pine exhausted
GB9402916D0 (en) * 1994-02-16 1994-04-06 Pfizer Ltd Antiparasitic agents
DE19520275A1 (de) † 1995-06-02 1996-12-05 Bayer Ag Endoparasitizide Mittel
BR9707473A (pt) 1996-01-30 1999-07-27 Takeda Chemical Industries Ltd Composto uso e processo para produção do mesmo e composição agroquímica
DE19612644A1 (de) † 1996-03-29 1997-10-02 Bayer Ag Oxadiazin-Derivate
FR2753377B1 (fr) 1996-09-19 1999-09-24 Rhone Merieux Nouvelle association parasiticide a base de 1-n-phenylpyra- zoles et de lactones macrocycliques endectocides
GB9825402D0 (en) * 1998-11-19 1999-01-13 Pfizer Ltd Antiparasitic formulations
FI107528B (fi) 1998-12-23 2001-08-31 Kemira Chemicals Oy Menetelmä muurahaishapon valmistamiseksi

Also Published As

Publication number Publication date
IL142104A (en) 2006-06-11
BG65440B1 (bg) 2008-08-29
CY1111955T1 (el) 2015-11-04
OA11678A (en) 2005-01-12
ES2237213T3 (es) 2009-08-19
HK1040593B (zh) 2004-10-08
EP1130966A1 (en) 2001-09-12
ID28698A (id) 2001-06-28
AR023062A1 (es) 2002-09-04
IS5907A (is) 2001-03-23
NO20012389D0 (no) 2001-05-15
IL173567A0 (en) 2006-07-05
EA003959B1 (ru) 2003-10-30
ZA997174B (en) 2001-05-18
CO5150175A1 (es) 2002-04-29
NZ510678A (en) 2003-08-29
PT1130966E (pt) 2005-04-29
KR20010080505A (ko) 2001-08-22
EP1130966B2 (en) 2009-05-27
JP3507799B2 (ja) 2004-03-15
PL348638A1 (en) 2002-06-03
DE69942465D1 (de) 2010-07-15
HRP20010368B1 (en) 2004-06-30
CA2351730A1 (en) 2000-06-02
PT1522219E (pt) 2010-07-19
CZ20011734A3 (cs) 2001-12-12
DE69923583D1 (de) 2005-03-10
SI1522219T1 (sl) 2010-09-30
SI1130966T1 (en) 2005-06-30
NO20012389L (no) 2001-05-15
SI1130966T2 (sl) 2009-08-31
PA8485501A1 (es) 2000-09-29
AU757892B2 (en) 2003-03-13
ATE469550T1 (de) 2010-06-15
DE69923583T2 (de) 2006-01-12
BG105601A (en) 2002-01-31
WO2000030449A1 (en) 2000-06-02
EP1522219A1 (en) 2005-04-13
DK1522219T3 (da) 2010-08-16
GB9825402D0 (en) 1999-01-13
EP1522219B1 (en) 2010-06-02
US6797701B2 (en) 2004-09-28
HU229493B1 (en) 2014-01-28
TNSN99213A1 (fr) 2005-11-10
EA200100458A1 (ru) 2001-10-22
CA2351730C (en) 2006-12-05
CN1147232C (zh) 2004-04-28
BR9915458B1 (pt) 2011-04-19
DK1130966T3 (da) 2005-05-09
HUP0104235A2 (hu) 2002-03-28
CN1326318A (zh) 2001-12-12
TW526045B (en) 2003-04-01
KR100458406B1 (ko) 2004-11-26
EP1130966B1 (en) 2005-02-02
PE20001319A1 (es) 2000-12-02
ATE288201T1 (de) 2005-02-15
UY25806A1 (es) 2001-08-27
AU5995999A (en) 2000-06-13
DE69923583T3 (de) 2009-12-24
PL204763B1 (pl) 2010-02-26
GT199900197A (es) 2001-05-10
HK1040593A1 (en) 2002-06-21
ES2344505T3 (es) 2010-08-30
DK1130966T4 (da) 2009-07-20
CZ304345B6 (cs) 2014-03-19
US20020028780A1 (en) 2002-03-07
HUP0104235A3 (en) 2004-03-01
MA25029A1 (fr) 2000-07-01
AP1210A (en) 2003-09-30
SK287540B6 (sk) 2011-01-04
IL142104A0 (en) 2002-03-10
HRP20010368A2 (en) 2002-06-30
YU23401A (sh) 2005-06-10
JP2002530302A (ja) 2002-09-17
SK6622001A3 (en) 2001-12-03
NZ537110A (en) 2006-04-28
BR9915458A (pt) 2001-07-17
AP9901697A0 (en) 1999-12-31

Similar Documents

Publication Publication Date Title
DZ2945A1 (fr) Formulations antiparasitaires contenant une avermectine ou milbémycine, et procédé pour leur préparation.
DZ2962A1 (fr) Dérivés de 3-azabicycloÄ3,1,0Ühexane nouveaux, procédé pour leur préparation et compositions les contenant.
DZ2889A1 (fr) 4-Carboxyamino-2-méthyl-1,2,3,4-tétrahydroquinoléines, procédé pour leur préparation et compositionspharmaceutiques les contenant.
DZ2891A1 (fr) Dérivés de tétrahydroquinoléines substués nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2963A1 (fr) Dérivés de bicycliques substituées nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
MA26659A1 (fr) Dérivés de benzimidazole nouveaux, compositions pharmaceutiques les contenant et procédé pour leur préparation.
DZ2890A1 (fr) 4-Carboxamino-2-substitué-1,2,3,4-tétrahydroquinoléines, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2197A1 (fr) Dérivés de 6-phénylpyridyl-2-amine, procédé pour leur préparation et compositions pharmaceutiques les contenant.
MA26551A1 (fr) Agonistes de prostaglandines nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
DZ1889A1 (fr) Dérivés de quinoléine nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2128A1 (fr) Composés nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ1878A1 (fr) Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
MA24529A1 (fr) Pyrazolopyrimidinones nouvelles, procede pour leur preparation et compositions les contenant .
FR2718450B1 (fr) Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
HK1043725A1 (en) Ethanolate of azithromycin, process for manufacture, and pharmaceutical compositions thereof.
DZ2753A1 (fr) Hydroxamides d'acides (4-arylsulfonylamino)-tétrahydropyranne-4-carboxyliques) procédé pour leur préparation et compositions les contenant.
DZ3045A1 (fr) Dérivés de i 3-méthyl-érythromycine nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2944A1 (fr) Azalides nouveaux, procédé our leur préparation etcompositions pharmaceutiques les contenant.
MA24484A1 (fr) Atropisomeres de 3-aryl-4(3h)-quinazolinones, procede pour leur preparation et compositions les contenant .
MA26414A1 (fr) Derives de quinoleine et de quinazoline nouveaux, procede pour leur preparation et formulations pharmaceutiques les contenant.
DZ2887A1 (fr) Dérivés d'azétidine, leur préparation et les médicaments les contenant.
DZ2217A1 (fr) Dérivés d'imidazole substitués, procédé pour leur préparation et compositions les contenant.
DZ2866A1 (fr) 1-Aryl-3-arylméthyl-1,8-naphtyridine-4-(1H)-ones nouvelles, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2777A1 (fr) Dérivés de quinazolinamines nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2188A1 (fr) Dérivés de quinoxalinedone, procédés et intermédiaires pour leur préparation et compositions pharmaceutiques les contenant.